(Q33543425)

27 July 2017

1 reference

title

Factor V Leiden mutation: a nursing perspective (English)

1 reference

27 July 2017

1 reference

Page MJ

1

1 reference

27 July 2017

publication date

1 December 1998

1 reference

Journal of Vascular Nursing

27 July 2017

published in

1 reference

27 July 2017

volume

16

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

73-77

1 reference

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Relation of three genetic traits to venous thrombosis in an African-American population

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

World distribution of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Activated protein C resistance can be associated with recurrent fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Antenatal screening for factor V Leiden mutation: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

Use of compression stockings

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2898%2990010-3

7 January 2021

10.1016/S1062-0303(98)90010-3

Identifiers

DOI

1 reference

27 July 2017

1 reference